Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumour in humans and has a very poor prognosis. The existing treatments have had limited success in increasing overall survival. Thus, identifying and understanding the key molecule(s) responsible for the maligna...
Main Authors: | Olivia G. Taylor, Joshua S. Brzozowski, Kathryn A. Skelding |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00963/full |
Similar Items
-
The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention
by: Joshua S. Brzozowski, et al.
Published: (2019-01-01) -
Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
by: Jen-Fu Hsu, et al.
Published: (2021-01-01) -
Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01) -
Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01) -
Drug target ranking for glioblastoma multiforme
by: Radhika Saraf, et al.
Published: (2021-04-01)